HemaSphere (Jun 2022)
PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT-MDS-1)
- A. DeZern,
- G. Marconi,
- D. Deeren,
- M. Diez Campelo,
- M. Lübbert,
- P. Krishnamurthy,
- Z. Nagy,
- G. Basak,
- A. Jonášová,
- E. Morozova,
- K. Geissler,
- Y. Ofran,
- H. Kelley,
- A. Volkert,
- K. Baker,
- Q. Kang-Fortner,
- G. Hodgson,
- C. Madigan,
- D. A. Roth,
- M. Kelly,
- P. Fenaux
Affiliations
- A. DeZern
- 1 Johns Hopkins University, Baltimore, United States of America
- G. Marconi
- 2 Romagnolo Institute to Study Tumors “Dino Amadori”, Meldola, Italy
- D. Deeren
- 3 AZ Delta, Roeselare, Belgium
- M. Diez Campelo
- 4 Hospital Universitario de Salamanca, Salamanca, Spain
- M. Lübbert
- 5 UniversitätKlinikum Freiburg, Freiburg, Germany
- P. Krishnamurthy
- 6 King’s College Hospital, London, United Kingdom
- Z. Nagy
- 7 Semmelweis University, Department of Internal Medicine and Hematology, Budapest, Hungary
- G. Basak
- 8 Medical University of Warsaw, Warsaw, Poland
- A. Jonášová
- 9 General University Hospital Prague, Prague, Czechia
- E. Morozova
- 10 Gorbacheva Research Institute, St. Petersburg, Russia
- K. Geissler
- 11 Hospital Hietzing, Vienna, Austria
- Y. Ofran
- 12 Department of Hematology, Shaare Zedek Medical Center, Faculty of Medicine Hebrew University of Jerusalem, Jerusalem, Israel
- H. Kelley
- 13 Syros Pharmaceuticals, Inc, Cambridge, United States of America
- A. Volkert
- 13 Syros Pharmaceuticals, Inc, Cambridge, United States of America
- K. Baker
- 13 Syros Pharmaceuticals, Inc, Cambridge, United States of America
- Q. Kang-Fortner
- 13 Syros Pharmaceuticals, Inc, Cambridge, United States of America
- G. Hodgson
- 13 Syros Pharmaceuticals, Inc, Cambridge, United States of America
- C. Madigan
- 13 Syros Pharmaceuticals, Inc, Cambridge, United States of America
- D. A. Roth
- 13 Syros Pharmaceuticals, Inc, Cambridge, United States of America
- M. Kelly
- 13 Syros Pharmaceuticals, Inc, Cambridge, United States of America
- P. Fenaux
- 14 Hôpital Saint Louis, Paris, France
- DOI
- https://doi.org/10.1097/01.HS9.0000850536.85159.f8
- Journal volume & issue
-
Vol. 6
pp. 1800 – 1801
Abstract
No abstracts available.